We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$26.1B
AUM Growth
+$1.03B
Cap. Flow
-$146M
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$94.2M
2
MDT icon
Medtronic
MDT
+$83.5M
3
VZ icon
Verizon
VZ
+$54.1M
4
ADBE icon
Adobe
ADBE
+$54.1M
5
AMZN icon
Amazon
AMZN
+$50.7M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$81.3M
2
ST icon
Sensata Technologies
ST
+$78M
3
PCG icon
PG&E
PCG
+$52M
4
AMGN icon
Amgen
AMGN
+$43.5M
5
LOW icon
Lowe's Companies
LOW
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.49%
2 Healthcare 15.46%
3 Consumer Discretionary 11.2%
4 Financials 11.13%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSIT icon
1226
Insight Enterprises
NSIT
$3.85B
$281K ﹤0.01%
5,750
IGE icon
1227
iShares North American Natural Resources ETF
IGE
$733M
$280K ﹤0.01%
7,590
+300
+4% +$10.8K
FISI icon
1228
Financial Institutions
FISI
$812M
$276K ﹤0.01%
8,400
SHOE
1229
Shoe Station Group
SHOE
$424M
$276K ﹤0.01%
+17,000
New +$237K
CVE icon
1230
Cenovus Energy
CVE
$54.2B
$271K ﹤0.01%
26,064
-6,230
-19% -$62.8K
PPL
1231
PPL Corp
PPL
$26.9B
$271K ﹤0.01%
9,509
-9,392
-50% -$260K
OMED
1232
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$270K ﹤0.01%
116,785
-15,000
-11% -$43.7K
BBGI icon
1233
Beasley Broadcasting Group
BBGI
$35.3M
$267K ﹤0.01%
1,191
CUBI icon
1234
Customers Bancorp
CUBI
$2.66B
$267K ﹤0.01%
+9,400
New +$281K
OVV icon
1235
Ovintiv
OVV
$17B
$267K ﹤0.01%
4,085
-345
-8% -$21.6K
QMCO icon
1236
Quantum Corp
QMCO
$411M
$267K ﹤0.01%
6,059
-3,021
-33% -$203K
LPT
1237
DELISTED
Liberty Property Trust
LPT
$266K ﹤0.01%
6,001
+187
+3% +$7.92K
CORT icon
1238
Corcept Therapeutics
CORT
$9.98B
$264K ﹤0.01%
16,800
-3,800
-18% -$66.1K
BLCM
1239
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$263K ﹤0.01%
+3,570
New +$278K
MGIC
1240
DELISTED
Magic Software Enterprises
MGIC
$261K ﹤0.01%
31,400
BSV icon
1241
Vanguard Short-Term Bond ETF
BSV
$44.7B
$260K ﹤0.01%
+3,330
New +$260K
QEP
1242
DELISTED
QEP RESOURCES, INC.
QEP
$260K ﹤0.01%
21,200
-56,700
-73% -$674K
DBI icon
1243
Designer Brands
DBI
$315M
$258K ﹤0.01%
10,000
DINO icon
1244
HF Sinclair
DINO
$16.2B
$258K ﹤0.01%
3,769
-730
-16% -$48.6K
EWH icon
1245
iShares MSCI Hong Kong ETF
EWH
$1.23B
$258K ﹤0.01%
10,677
IMMR icon
1246
Immersion
IMMR
$243M
$255K ﹤0.01%
+16,500
New +$221K
SMMF
1247
DELISTED
Summit Financial Group, Inc.
SMMF
$254K ﹤0.01%
9,465
AN icon
1248
AutoNation
AN
$7.7B
$253K ﹤0.01%
+5,200
New +$246K
CHH icon
1249
Choice Hotels
CHH
$5.26B
$249K ﹤0.01%
3,300
-10,600
-76% -$850K
PSCE icon
1250
Invesco S&P SmallCap Energy ETF
PSCE
$94M
$247K ﹤0.01%
2,914
-326
-10% -$26.7K

Similar funds

Axa's Q2 2018 Portfolio in Review

As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
  • Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
  • Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
  • Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
  • Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
  • Axa opened 112 new positions and closed 130 in Q2 2018.
  • Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.

Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.